• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURAVI LTD. EMBOTRAP II 5X33 REVASC. DEV.; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURAVI LTD. EMBOTRAP II 5X33 REVASC. DEV.; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number ET007533
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/08/2021
Event Type  malfunction  
Manufacturer Narrative
Product complaint #: (b)(4).The purpose of this mdr submission is to report the findings of the device investigation.The inner channel was fractured, meeting regulatory reporting criteria.Information regarding patient race and ethnicity was not reported.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: a report from the field indicated that the (b)(6) male patient underwent endovascular mechanical thrombectomy of a left middle cerebral artery (mca) (m1-m2) occlusion with a 5mm x 33mm embotrap ii revascularization device (et007533/20m084av).During the procedure, three passes were made with the embotrap via a prowler select plus microcatheter (product code & lot number unknown).However, the clot was not able to be retrieved.Therefore, the physician replaced the embotrap device with a 6mm x 40mm solitaire stent retriever (medtronic) and the clot was able to be retrieved in one pass.The procedure was completed successfully.The surgery was delayed 20 minutes due to the event.There was no report of patient injury.The initial examination of the returned embotrap device identified fractures present on the distal section of the inner channel.Fractures were present on the inner channel spring feature and one of the inner channel expanded struts.There was also deformation present on the inner channel spring feature consistent with a tensile force.No evidence of any further damage or deformation was present on the device.The visual inspection also indicates that the returned embotrap device was correctly assembled and manufactured, with all adhesive bonds and joints complete and undamaged.The returned embotrap device failed to fully retract through a 0.0195¿ id tube, indicating that the fractures present on the inner channel have affected the collapsing profile of the returned device.The ptfe insertion tool was dimensionally inspected and found to be within specification for the inner and outer diameter.Clot retrieval attempts were carried out with the returned device.The returned device was successfully delivered and deployed in a sample prowler select plus microcatheter.Clot engagement was achieved, where the device successfully deployed within the clot, flow restoration was visually observed and the returned embotrap device successfully retrieved the clot (with aspiration) to the aspiration catheter tip.This indicates that the returned embotrap device is capable of correct clot engagement and clot retrieval.It is probable that other patient or procedure specific factors may have impacted clot retrieval performance of the returned device during the complaint event.The damage noted during visual inspection (i.E.Deformation of the spring feature and fractures of the inner channel expanded struts and spring feature) is consistent with a material failure under tension.Sem analysis of the appearance of the fracture faces on the inner channel of the returned device also indicates the fractures are consistent with a material failure under tension.A review of the manufacturing documentation associated with s lot 20m084av presented no issues during the manufacturing or inspection process that can be related to the reported complaint.Although no device damage was reported in the complaint, the returned embotrap device has fractures and deformation present on the distal section of the inner channel.It is unknown when the damage noted occurred but as the damage is very obvious it is unlikely that it occurred prior to or during the use by the physician.The device was returned in packaging similar to the embotrap protective packaging but the ability to insert and remove the device from the packaging used to return the device without damage to the device is not proven.No further damage was observed on the returned device.Despite the damage to the device the returned embotrap was successfully delivered through a sample prowler select plus microcatheter, successfully engaged with clot and successfully retrieved clot when used with aspiration.This demonstrates that the damage noted does not impact the ability of the device to retrieve a blood clot and it is concluded that the damage is therefore not a contributor to the event reported and likely to have been caused after the event reported.The damage and deformation present on the device are consistent with damage as a result of application of a tensile force.No high forces or difficulty during use during the complaint event were reported as part of the complaint.As the returned device successfully retrieved the clot under test conditions it can be concluded that the most likely causes of the failure to retrieve the clot in the event reported are procedural and/or patient specific factors such as vessel tortuosity.As concluded, the device damage occurred post its use in the procedure, the performance of the undamaged device in delivery, clot engagement and withdrawal would be improved over the performance demonstrated in this investigation.Treatment failure is a known potential outcome associated with endovascular mechanical thrombectomy.The embotrap ii revascularization device is intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion.The root cause of the inability to achieve a mtici score of =2b with three embotrap passes cannot be determined.However, there are clinical and procedural factors including clot burden/ characteristics, vessel characteristics, anatomical challenges, device interaction, and operator technique that may have contributed.The file will be re-reviewed if additional information is received at a later date.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Event Description
A report from the field indicated that the (b)(6) male patient underwent endovascular mechanical thrombectomy of a left middle cerebral artery (mca) (m1-m2) occlusion with a 5mm x 33mm embotrap ii revascularization device (et007533/20m084av).During the procedure, three passes were made with the embotrap via a prowler select plus microcatheter (product code & lot number unknown).However, the clot was not able to be retrieved.Therefore, the physician replaced the embotrap device with a 6mm x 40mm solitaire stent retriever (medtronic) and the clot was able to be retrieved in one pass.The procedure was completed successfully.The surgery was delayed 20 minutes due to the event.There was no report of patient injury.Based on the analysis of the device received, the inner channel was fractured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOTRAP II 5X33 REVASC. DEV.
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
NEURAVI LTD.
block 3 ballybritt
business park
galway H91 K 5YD
EI  H91 K5YD
Manufacturer (Section G)
ADVANT MEDICAL
parkmore business park west
galway H91 P V0V
EI   H91 PV0V
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13211127
MDR Text Key290282899
Report Number3011370111-2022-00004
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K173452
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/24/2023
Device Catalogue NumberET007533
Device Lot Number20M084AV
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/07/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
6MM X 40MM SOLITAIRE STENT RETRIEVER (MEDTRONIC).; PROWLER SELECT PLUS MICROCATHETER.
Patient Age87 YR
Patient SexMale
Patient Weight78 KG
-
-